COMMUNIQUÉS West-GlobeNewswire

Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025
18/08/2025
INFORMATIONS RÉGLEMENTÉES Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025 La FDA approuve le système Genio® pour le marché américain ; la Société lance la commercialisation du [...]
Nyxoah Reports Second Quarter Financial and Operating Results
18/08/2025
REGULATED INFORMATION Nyxoah Reports Second Quarter Financial and Operating Results FDA Approves Genio® System for U.S. Market; Company Begins Commercial Launch Mont-Saint-Guibert, Belgium – August 18, 2025, 10:10pm CET [...]
Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
18/08/2025
GARDNER, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
18/08/2025
First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Iovance [...]
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
18/08/2025
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical [...]
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
18/08/2025
WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) [...]
Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)
18/08/2025
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA ® (pemivibart) against XFG Centers for Disease Control data and wastewater surveillance data indicate XFG variant appears to [...]
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2025
CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, between August 4, 2025, and [...]
Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery
18/08/2025
WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced that Founder and CEO of Tevogen, Dr. Ryan Saadi, donated 10,000 of his personal shares [...]
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
18/08/2025
WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced that its Founder and CEO, Dr. Ryan Saadi, has donated 10,000 of his personal shares of [...]
Attelia Dental Clinic Wins Prestigious Quality Choice Prize 2025 in Stockholm
18/08/2025
Photo: Founder and Chief Dentist Dr. Mehmet İşlek of Attelia Dental Clinic receiving the Quality Choice Prize 2025 award. ANTALYA, Turkey, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Attelia Oral & Dental Health Center , a [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juillet 2025
18/08/2025
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares - July 2025
18/08/2025
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
18/08/2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study [...]
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
18/08/2025
CHICAGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, announced today its financial results for [...]
WePrevent Launches Florida’s First Comprehensive Prevention Health Platform Amid $100B Chronic Disease Crisis
18/08/2025
Miami, Florida , Aug. 18, 2025 (GLOBE NEWSWIRE) -- WePrevent , a Florida-based health innovation company, today announced the launch of WePrevent.org , the state’s first comprehensive online platform connecting [...]
BioNTX Announces 2025 Tech Transfer Showcase Finalists Pitch Competition at the 2025 iC³® Life Science & Healthcare Innovation Summit
18/08/2025
DALLAS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- BioNTX is pleased to announce the finalists for the Annual Southwest Tech Transfer Showcase , set for Wednesday, September 17th, at the 2025 iC³® Life Science & Healthcare [...]
Cuprina Reaffirms Commitment to Shareholders and Patients Following Recent Stock Market Activity
18/08/2025
Singapore, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited ( Nasdaq: CUPR ) (“ Cuprina ” or “ the Company ”) issued the following statement in response to recent unusual trading activity and [...]
OncoC4 Strengthens Leadership Team with Appointment of Shiniu Wei as Chief Financial Officer
18/08/2025
ROCKVILLE, Md., Aug. 18, 2025 (GLOBE NEWSWIRE) -- OncoC4, Inc., a late-stage biopharmaceutical company developing novel medicines for cancer today announced the appointment of Shiniu Wei as Chief Financial Officer (CFO [...]

Pages